Archives

by in
Entry Author Date Location
Rib-X Inks Research Agreement With Sanofi 07/06/11 Boston
Optimer Wins FDA Approval of New Antibiotic for Hospital Infections 05/27/11 San Diego
Optimer Cruises Into Memorable Memorial Day Weekend, Awaiting FDA Word on Antibiotic 05/27/11 San Diego
Nestlé Acquires Prometheus, Trius Raises $30M in Private Placement, Canaan’s Bloch Discusses Advanced BioHealing Deal, & More San Diego Life Sciences News 05/26/11 San Diego
San Diego’s Trius Therapeutics Creates Options for the Next Generation of Antibiotics 05/25/11 San Diego
Kleiner Perkins’ Bet on a Concrete Stomach, The Gates Foundation’s Out-of-the-Box Ideas, & More Seattle-Area Life Sciences News 05/05/11 Seattle
Optimer Spokeswoman Killed 05/04/11 San Diego
Kilimanjaro Energy Seeks to Pop Loose Trillions’ Worth of Underground Oil, Save the World 05/02/11 San Francisco
Indel Grabs $1.4M for Antibiotics 04/28/11 Seattle
Xenoport Wins FDA Green Light, The Coming ‘HealthTech’ Wave, More Genomes Go Public, & More Bay Area Life Sciences News 04/08/11 San Francisco
Optimer Antibiotic Gets Panel Nod, CareFusion Buys Vestara, Tracon Raises $16.5M, & More San Diego Life Sciences News 04/07/11 San Diego
Omeros Flunks Pivotal Trials, Dendreon’s Shareholder Hubbub, AVI Biopharma Nabs $30M, & More Seattle-Area Life Sciences News 04/07/11 Seattle
Optimer Inks Potential $47.5M-Plus Deal with Cubist to Help Sell Antibiotic 04/06/11 San Diego
Optimer Wins FDA Panel Nod, Still Wrestling With Language to Describe Benefit 04/05/11 San Diego
Cubist Settles Key Litigation 04/05/11 Boston
Biotechies Need to Get Serious About Antibiotics, Where There is Money to Be Made 04/04/11 National
Optimer Nabs $68M in Stock Sale 02/11/11 San Diego
Optimer Pockets $68M Upfront From Astellas For Rights to Antibiotic in Europe 02/07/11 San Diego
Rib-X Raises Another $20M, Led by Warburg Pincus, to Develop Late Stage Antibiotics 01/11/11 Boston
E-Commerce Pioneer Sets Up Cancer Commons, Affymax Hires New Boss, Plexxikon Opts In, & More Bay Area Life Sciences News 01/07/11 San Francisco
Genentech Licenses AMRI Compounds 01/04/11 Seattle
Avalon Funds Antibiotics Development at New Startup, RQx Pharmaceuticals 12/14/10 San Diego
Optimer Seeks Quick Green Light From FDA for Antibiotic Against Deadly Bug 11/30/10 San Diego
Glaxo Buys $129M in Theravance Stock 11/29/10 San Francisco
Optimer Halts Study After Antibiotic for Traveler’s Diarrhea Linked to Rash; Shares Drop 11/10/10 San Diego
Cytomx Pockets $30M, AvidBiotics Eyes Food Safety Market, Rigel Passes Arthritis Trial, & More Bay Area Life Sciences News 09/24/10 San Francisco
AvidBiotics Creates Novel Proteins that Kill Bacteria on the Farm, in the Lab, in the Body 09/21/10 San Francisco
Tetraphase Shows What the $45M Was All About at Big Antibiotics Conference 09/15/10 Boston
Why We Think Investing in Antibiotics Makes Sense 09/14/10 San Francisco
Trius Ends First Day Trading at $5 a Share 08/03/10 San Diego
Page 2 of 4 « previous page · next page »

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.